BAT

Product NDC
60492-0075
11-digit product format
604920075
Labeler code
60492
Product ID
60492-0075_2e94a3f2-2cd8-40bb-ae96-80dd2928c797
Type
PLASMA DERIVATIVE
Nonproprietary name
Botulism Antitoxin Heptavalent
Dosage form
LIQUID
Route
INTRAVENOUS
Labeler
Emergent BioSolutions Canada Inc
Application
BLA125462
Marketing category
BLA
Marketing start
2013-03-01
Substance
EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2
Active strength
4500; 3300; 3000; 600; 5100; 3000; 600 [iU]/10mL; [iU]/10mL; [iU]/10mL; [iU]/10mL; [iU]/10mL; [iU]/10mL; [iU]/10mL
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
BAT
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB24500 [iU]/10mL
EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB23300 [iU]/10mL
EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB23000 [iU]/10mL
EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2600 [iU]/10mL
EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB25100 [iU]/10mL
EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB23000 [iU]/10mL
EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2600 [iU]/10mL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
60492-0075-1BAT50 mL in 1 VIAL, GLASSLIQUID5010
60492-0075-2BAT6 in 1 CARTONLIQUID610
60492-0075-4BAT1 in 1 CARTONLIQUID110

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
60492-0075-2EA - Each60492-00754a220678-dde9-4d44-b445-a95ef00baaf012024-11-05

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2ACTIVE INGREDIENTLE3J6I6DXPBAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]1
EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2ACTIVE INGREDIENTVSK09VP4HLBAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]1
EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2ACTIVE INGREDIENTX5I2P7E9TYBAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]1
EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2ACTIVE INGREDIENT30Y9N0SEBEBAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]1
EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2ACTIVE INGREDIENTT95649SUV7BAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]1
EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2ACTIVE INGREDIENTRJN8G983LQBAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]1
EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2ACTIVE INGREDIENT943578J0XGBAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]1
EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2ACTIVE MOIETYLE3J6I6DXPBAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]1
EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2ACTIVE MOIETYVSK09VP4HLBAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]1
EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2ACTIVE MOIETYX5I2P7E9TYBAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]1
EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2ACTIVE MOIETY30Y9N0SEBEBAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]1
EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2ACTIVE MOIETYT95649SUV7BAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]1
EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2ACTIVE MOIETYRJN8G983LQBAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]1
EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2ACTIVE MOIETY943578J0XGBAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [CANGENE CORPORATION]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
60492-0075BAT (BOTULISM ANTITOXIN HEPTAVALENT) LIQUID [EMERGENT BIOSOLUTIONS CANADA INC.]9Current NDC, Legacy NDC, 3 package rows20210622_9f3c4292-8773-4781-8264-d71c80d3eabd.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1722719botulism antitoxin heptavalent (A, B, C, D, E, F, G), Equine InjectionPSN9f3c4292-8773-4781-8264-d71c80d3eabd10
1722719botulinum neurotoxin A immune FAB2, equine 4500 UNT / botulinum neurotoxin B immune FAB2, equine 3300 UNT / botulinum neurotoxin C immune FAB2, equine 3000 UNT / botulinum neurotoxin D immune FAB2, equine 600 UNT / botulinum neurotoxin E immune FAB2, equine 5100 UNT / botulinum neurotoxin F immune FAB2, equine 3000 UNT / botulinum neurotoxin G immune FAB2, equine 600 UNT InjectionSCD9f3c4292-8773-4781-8264-d71c80d3eabd10
1722719botulism antitoxin heptavalent (A, B, C, D, E, F, G), Equine InjectionSY9f3c4292-8773-4781-8264-d71c80d3eabd10

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
60492-0075-16049200750150 mL in 1 VIAL, GLASS50 mlHistorical
60492-0075-2604920075026 VIAL, GLASS in 1 CARTON (60492-0075-2) / 50 mL in 1 VIAL, GLASS (60492-0075-1) 2013-03-010000-00-00NoNoCurrent
60492-0075-36049200750320 mL in 1 VIAL, GLASS (60492-0075-3) 20 ml2013-03-010000-00-00NoNoCurrent
60492-0075-4604920075041 VIAL, GLASS in 1 CARTON (60492-0075-4) / 50 mL in 1 VIAL, GLASS (60492-0075-1) 2013-03-010000-00-00NoNoCurrent